Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 8 matching records.
8 results — page 1 of 1
- Level ARandomized Controlled TrialPubMed
Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
Randomized Controlled Trial with a reported sample of 283 on Autoimmune Research, published in Gastroenterology (2026) — summary generated from the PubMed abstract.
- 2026
- n = 283
Gastroenterology3 citations - Level CProspective StudyPubMed
[A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
Prospective Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Nihon Yakurigaku Zasshi (2024) — summary generated from the PubMed abstract.
- 2024
Nihon Yakurigaku Zasshi - Level BClinical TrialPubMed
Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease.
Clinical Trial with a reported sample of 513 on Autoimmune Research, published in BMC Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 513
BMC Gastroenterol1 citations - Level CCase Report / SeriesPubMed
Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
Case Report / Series with a reported sample of 27 on Autoimmune Research, published in Tech Coloproctol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 27
Tech Coloproctol - Level ASystematic ReviewPubMed
Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
Systematic Review on Autoimmune Research, published in Ann Gastroenterol (2023) — summary generated from the PubMed abstract.
- 2023
Ann Gastroenterol6 citations - Level BRandomized Controlled TrialPubMed
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Randomized Controlled Trial with a reported sample of 25 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 25
Dis Colon Rectum103 citations - Level BRandomized Controlled TrialPubMed
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
Randomized Controlled Trial on Autoimmune Research, published in Inflamm Bowel Dis (2022) — summary generated from the PubMed abstract.
- 2022
Inflamm Bowel Dis40 citations - Level DNarrative ReviewPubMed
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
Narrative Review on Autoimmune Research, published in Drugs Today (Barc) (2019) — summary generated from the PubMed abstract.
- 2019
Drugs Today (Barc)
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406